Molecular analysis of WFDC1/ps20 gene in prostate cancer

Prostate

Volumn 61, Issue 2, 2004, Pages 192-199

  Watson, J E Vivienne ^a   Kamkar, Shervin ^a   James, Karen ^a   Kowbel, David ^a   Andaya, Armann ^a   Paris, Pamela L ^a   Simko, Jeffry ^a   Carroll, Peter ^b   McAlhany, Stephanie ^c   Rowley, David ^c   Collins, Colin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

16q23.1; Prostate cancer; ps20; Stroma; WFDC1

Indexed keywords

ACID PROTEIN; COMPLEMENTARY DNA; DNA; RNA; UNCLASSIFIED DRUG; WHEY ACIDIC PROTEIN TYPE FOUR DISULFIDE CORE;

ARTICLE; CANCER PATIENT; CELL LINE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; EPITHELIUM; EXON; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC SCREENING; HUMAN; HUMAN CELL; HUMAN TISSUE; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA; TISSUE SECTION;

CELL LINE; CELL LINE, TUMOR; DNA, NEOPLASM; GENE EXPRESSION; HUMANS; MALE; MUTATION; POLYMORPHISM, GENETIC; PROSTATE; PROSTATIC NEOPLASMS; PROTEINS; RNA, NEOPLASM; SEQUENCE ANALYSIS, DNA;

EID: 4544283690     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.20100     Document Type: Article

References (24)

1. Rowley DR, Dang TD, Larsen M, Gerdes MJ, McBride L, Lu B. Purification of a novel protein (ps20) from urogenital sinus mesenchymal cells with growth inhibitory properties in vitro. J Biol Chem 1995;270(37):22058-22065.
2. Larsen M, Ressler SJ, Lu B, Gerdes MJ, McBride L, Dang TD, Rowley DR. Molecular cloning and expression of ps20 growth inhibitor. J Biol Chem 1998;273(8):4574-4584.
3. Clauss A, Lilja H, Lundwall A. A locus on human chromosome 20 contains several genes expressing protease inhibitor domains with homology to whey acidic protein. Biochem J 2002;368(Pt 1): 233-242.
4. Wiedow O, Schroder J, Gregory H, Young J, Christophers E. Elafin: An elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence [published erratum appears in J Biol Chem 1991 Feb 15;266(5):3356]. J Biol Chem 1990;265(25):14791-14795.
5. Wiedow O, Schroder J, Gregory H, Young J, Christophers E. Elafin: An elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence [published erratum appears in J Biol Chem 1991 Feb 15;266(5):3356]. J Biol Chem 1990;265(25):14791-14795.
6. Thompson RC, Ohlsson K. Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc Natl Acad Sci USA 1986;83(18):6692-6696.
7. McAlhany SJ, Ressler SJ, Larsen M, Tuxhorn JA, Yang F, Dang TD, Rowley DR. Promotion of Angiogenesis by ps20 in the Differential Reactive Stroma Prostate Cancer Xenograft Model. Cancer Res 2003;63(18):5859-5865.
8. Larsen M, Ressler SJ, Gerdes MJ, Lu B, Byron M, Lawrence JB, Rowley DR. The WFDC1 gene encoding ps20 localizes to 16q24, a region of LOH in multiple cancers. Mamm Genome 2000;11(9): 767-773.
9. Elo JP, Harkonen P, Kyllonen AP, Lukkarinen O, Poutanen M, Vihko R, Vihko P. Loss of heterozygosity at 16q24.1-q24.2 is significantly associated with metastatic and aggressive behavior of prostate cancer. Cancer Res 1997;57(16):3356-3359.
10. Chu LW, Troncoso P, Johnston DA, Liang JC. Genetic markers useful for distinguishing between organ-confined and locally advanced prostate cancer. Genes Chromosomes Cancer 2003;36(3):303-312.
11. Paris PL, Witte JS, Kupelian PA, Levin H, Klein EA, Catalona WJ, Casey G. Identification and fine mapping of a region showing a high frequency of allelic imbalance on chromosome 16q23.2 that corresponds to a prostate cancer susceptibility locus. Cancer Res 2000;60(13):3645-3649.
12. Gong G, DeVries S, Chew KL, Cha I, Ljung BM, Waldman FM. Genetic changes in paired atypical and usual ductal hyperplasia of the breast by comparative genomic hybridization. Clin Cancer Res 2001;7(8):2410-2414.
13. Roylance R, Gorman P, Hanby A, Tomlinson L. Allelic imbalance analysis of chromosome 16q shows that grade I and grade III invasive ductal breast cancers follow different genetic pathways. J Pathol 2002;196(1):32-36.
14. Yakicier MC, Legoix P, Vaury C, Gressin L, Tubacher E, Capron F, Bayer J, Degott C, Balabaud C, Zucman-Rossi J. Identification of homozygous deletions at chromosome 16q23 in aflatoxin B1 exposed hepatocellular carcinoma. Oncogene 2001;20(37):5232-5238.
15. Watson JE, Doggett NA, Albertson DG, Andaya A, Chinnaiyan A, van Dekken H, Ginzinger D, Haqq C, James K, Kamkar S, Kowbel D, Pinkel D, Schmitt L, Simko JP, Volik S, Weinberg VK, Paris PL, Collins C. Integration of high resolution array comparative genomic hybridization analysis of chromosome 16q with expression array data refines common regions of loss at 16q23-qter and identifies underlying candidate tumor suppressor genes in prostate cancer. Oncogene 2004 (in press).
16. Saffroy R, Riou P, Soler G, Azoulay D, Emile JF, Debuire B, Lemoine A. Analysis of alterations of WFDC1, a new putative tumour suppressor gene, in hepatocellular carcinoma. Eur J Hum Genet 2002;10(4):239-244.
17. Kurose K, Gilley K, Matsumoto S, Watson PH, Zhou XP, Eng C. Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. Nat Genet 2002;32(3):355-357.
18. Hayward SW, Dahiya R, Cunha GR, Bartek J, Deshpande N, Narayan P. Establishment and characterization of an immortalized but non- transformed human prostate epithelial cell line: BPH-1. In Vitro Cell Dev Biol Anim 1995;31(1):14-24.
19. Hayward SW, Wang Y, Cao M, Hom YK, Zhang B, Grossfeld GD, Sudilovsky D, Cunha GR. Malignant transformation in a non-tumorigenic human prostatic epithelial cell line. Cancer Res 2001;61(22):8135-8142.
20. Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Dang TD, Rowley DR. Reactive stroma in human prostate cancer: Induction of myofibroblast phenotype and extracellular matrix remodeling. Clin Cancer Res 2002;8(9):2912-2923.
21. Tlsty TD, Hein PW. Know thy neighbor: Stromal cells can contribute oncogenic signals. Curr Opin Genet Dev 2001;11(1): 54-59.
22. Paterson RF, Ulbright TM, MacLennan GT, Zhang S, Pan CX, Sweeney CJ, Moore CR, Foster RS, Koch MO, Eble JN, Cheng L. Molecular genetic alterations in the laser-capture-microdissected stroma adjacent to bladder carcinoma. Cancer 2003;98(9):1830-1836.
23. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 1999;59(19):5002-5011.
24. Tuxhorn JA, McAlhany SJ, Dang TD, Ayala GE, Rowley DR. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model. Cancer Res 2002;62(11):3298-3307.